|
MYST3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.406500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.533900E-02 |
| Normal-vs-Stage2 |
1.901700E-02 |
| Normal-vs-Stage3 |
1.10709999945335E-07 |
| Normal-vs-Stage4 |
1.11109999978432E-07 |
| Stage1-vs-Stage2 |
2.851200E-01 |
| Stage1-vs-Stage3 |
2.37969999999921E-05 |
| Stage1-vs-Stage4 |
2.27090000000096E-05 |
| Stage2-vs-Stage3 |
1.127370E-01 |
| Stage2-vs-Stage4 |
4.772100E-02 |
| Stage3-vs-Stage4 |
5.772000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.559600E-04 |
| Normal-vs-AfricanAmerican |
2.818800E-04 |
| Normal-vs-Asian |
5.756600E-01 |
| Caucasian-vs-AfricanAmerican |
2.058000E-01 |
| Caucasian-vs-Asian |
4.876400E-01 |
| AfricanAmerican-vs-Asian |
2.790400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.42000000000898E-05 |
| Normal-vs-Female |
9.737400E-03 |
| Male-vs-Female |
9.564200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.301500E-02 |
| Normal-vs-Age(41-60Yrs) |
8.355400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.91802999999213E-05 |
| Normal-vs-Age(81-100Yrs) |
5.177500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.798000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.193800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.826400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.682220E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.007800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.047400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.673030E-01 |
| Normal-vs-Grade 2 |
5.489900E-02 |
| Normal-vs-Grade 3 |
4.09570000026171E-07 |
| Normal-vs-Grade 4 |
1.93320000008157E-08 |
| Grade 1-vs-Grade 2 |
4.685700E-02 |
| Grade 1-vs-Grade 3 |
1.151030E-04 |
| Grade 1-vs-Grade 4 |
1.82276999999287E-05 |
| Grade 2-vs-Grade 3 |
1.377830E-04 |
| Grade 2-vs-Grade 4 |
2.20989999999421E-06 |
| Grade 3-vs-Grade 4 |
5.813600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.896200E-01 |
| Normal-vs-ccB subtype |
3.583000000007E-05 |
| ccA subtype-vs-ccB subtype |
5.5409999999978E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.009800E-04 |
| Normal-vs-N1 |
2.061200E-03 |
| N0-vs-N1 |
1.861650E-01 |
|
|
